Inflammation can be caused by various insults such as microbial infection and tissue
injury, and is a protective response of the body to ensure removal of detrimental stimuli
and to stimulate the repair of damaged tissues [1]. Inflammation is, however, also a major
pathophysiological factor in several illnesses such as sepsis, renal ischemia-reperfusion
(I/R) injury, and cancer. It is generally thought that a controlled inflammatory response
is beneficial (for example, in providing protection against infection), but that it becomes
detrimental if dysregulated (for example, in septic shock). Therefore, restoring proper
control of inflammatory reactions may be of benefit in pathological inflammatory
conditions. Although many experimental anti-inflammatory approaches have been
developed and tested, most of these have not led to successful clinical application.
Therefore, there is still an urgent need for novel approaches to better control inflammation
in severe clinical conditions. This thesis describes the immunomodulatory effects of
human chorionic gonadotropin (hCG)-related oligopeptides, dexamethasone, and dietary
restriction in animal models of sepsis, renal I/R injury, and cancer metastases, in which
inflammation is a central pathophysiological component.
No comments:
Post a Comment